UroGen Pharma

URGNNasdaq Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.295 B

$46.96 +2.98%

Close of 7 Aug 2026

Revenue

$109.8M

#2485 by revenue

Earnings

-$153.5M

Loss-making

Shares outstanding

48,880,564

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#99Sionna TherapeuticsSION$2.30B
#100Nuvation BioNUVB$2.30B
#101UroGen PharmaURGN$2.30B
#102Palvella TherapeuticsPVLA$2.27B
#103Mineralys TherapeuticsMLYS$2.26B

Where these numbers come from

Share counts and financials for UroGen Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.